Analytical Testing
Optimizing
Safety in ADCs and RNA-Based Therapies Using MTD Testing
Tina Rogers, Ph.D., MBA, DABT
Senior Technical Director
WuXi AppTec
April/May/June 2025 | Volume 26, Issue 2
Clinical Trials
A Sponsor’s
Perspective: Why Digital Adoption Lags in Clinical Trials
Sara Liu
Director, Client Delivery, Patient Centered Technology
IQVIA
Contract Manufacturing
January/February/March 2025 | Volume 26, Issue 1
Changing
Course in 2025 Toward Personalized Healthcare, Drug Development and Reduced Animal Testing
Dr. Isaac Bentwich, Founder and CEO
Quris-AI
January/February/March 2025 | Volume 26, Issue 1
Use of Expert Prior
Elicitation for Clinical Research
Giles Partington, Principal Statistician
Phastar
April/May/June 2025 | Volume 26, Issue 2
Beyond
Wearables: How Integrated BGM + eCOA Solutions are Solving
Real World Problems in Obesity Clinical Research
Melissa Mooney, Director
eCOA Sales Engineering at IQVIA (eCOA Technologies)
July/August/September | Volume 26, Issue 3
Contract Manufacturing
The Critical Role
of CDMOs in Advancing the Gene Editing Space
Melanie Cerullo
Chief Quality and Regulatory Officer
ReciBioPharm
January/February/March 2025 | Volume 26, Issue 1
CMO Quality Management Insights
Londa Ritchey, Quality Director
PharmaLex a Cencora Company
January/February/March 2025 | Volume 26, Issue 1
Rethinking
RNA Manufacturing: The Enzymatic Approach as a Scalable, Sustainable Alternative
Kevin Norrett, Chief Operating Officer
Codexis Inc.
April/May/June 2025 | Volume 26, Issue 2
Prefilled Syringes: Sterile Drug Delivery, Market Dynamics, CDMO Partnerships, and Market Outlook to
2030
Mike Auerbach
Editor-in-Chief
October/November/December | Volume 26, Issue 4
Quality: The Gold Standard for CDMOs - No Exceptions, No Compromises - Why quality isn’t a differentiator - it’s the
expectation
Jody Chastain
CEO
The Ritedose Corporation
October/November/December | Volume 26, Issue 4
Contract Research
Creating
a More Sustainable Future: Is Advanced Automation, Powered By AI, Pharma’s Only Chance to Stay Economically
Viable?
Aman Wasan
CEO
ArisGlobal
January/February/March 2025 | Volume 26, Issue 1
Custom Care:
Bioanalysis and the Future of Personalized Medicine
Jianbo Diao, PhD, Director of Bioanalytical Services (BAS),
Immunochemistry Team
WuXi AppTec
Xiaoying Jin, Senior Director of Suzhou Bioanalysis Department
WuXi AppTec
January/February/March 2025 | Volume 26, Issue 1
The
Evolving Global Biotech Opportunity: Navigating the Latest Market Entry Conditions to Optimize Product
Payback
Sam Tomlinson, Vice President of Global Drug Safety
Arriello
January/February/March 2025 | Volume 26, Issue 1
Going
Beyond the Hype to Unlock the AI Advantage in Clinical Development
Dr. Jennifer Bradford
VP, Head of Data Science
Coronado Research
April/May/June 2025 | Volume 26, Issue 2
The
Great AI Dichotomy: How to be Ready for a Fast-Changing Future That’s Already Here
Jason Bryant, Vice President, Product Management for AI & Data
ArisGlobal
April/May/June 2025 | Volume 26, Issue 2
Unveiling
the Impact of Residual Carbon Content on Elemental Impurities in Pharmaceuticals: A Comprehensive
Evaluation
Andrei Izmer, Analytical Technical Leader
Almac Sciences
April/May/June 2025 | Volume 26, Issue 2
2025:
The Year of the DAP (Digital Adoption Platform) as an Aid to GxP System Compliance
Sabine Gölden, eLearning and Training Lead
MAIN5
April/May/June 2025 | Volume 26, Issue 2
Challenges
in Developing Analytical Procedures with the New ICH Q14 Guideline
Trevor Williams, Pii, A Jabil Company
Kim Huynh-Ba, Pharmalytik, LLC
july/August/September | Volume 26, Issue 3
PV
Automation Next Steps: Solving the Significant Headache of Local Literature Monitoring
Jean Redmond, PhD, COO
Biologit
july/August/September | Volume 26, Issue 3
An
ADME Guide for Successful siRNA Therapeutics: Insights from Approved Drugs
Dr. Yan Pan, Associate Director, DMPK Department
WuXi AppTec
july/August/September | Volume 26, Issue 3
Why
Pharma AI Projects Fail: The Human Problem Behind Technical Success
Eric Karofsky
VectorHX
july/August/September | Volume 26, Issue 3
A
Critical Inflection Point: The Indisputable Case for Next-Gen Pharmacovigilance
John Cogan, COO
Qinecsa
july/August/September | Volume 26, Issue 3
HPLC-Based Strategies for Impurity Profiling and Validation in Standard Drug Analysis
Priyanka Suresh Ghugare, Department of Quality Assurance, NIMS University, Dr BS
Tomar City, NH-11C, Highway, Jaipur Delhi, Chandwaji, Rajasthan 303121
Sandeep Kumar, Department of Pharmaceutics, NIMS University, Dr BS
Tomar City, NH-11C, Highway, Jaipur Delhi, Chandwaji, Rajasthan 303121
October/November/December | Volume 26, Issue 4
Sustaining the Future of Life Science Product Research
Lori A. Ball, CEO, Astoriom
Philip Bradley, General Manager, Astoriom
October/November/December | Volume 26, Issue 4
Limitations of Existing Life Science Software - and the Opportunity to Evolve
Phil Mounteney
VP Science and Technology
Dotmatics
October/November/December | Volume 26, Issue 4
Future-Proofing Pharmacovigilance in an AI Era
Ana Pedro Jesuíno
Associate Director of Marketed Product Safety
IQVIA
October/November/December | Volume 26, Issue 4
Horizon Lines
A Quarterly
Review of NDAs – October - December, 2024
Neelam Sharma, Lavanya Kundurthy and Hemant N. Joshi, Ph.D., MBA
Tara Innovations LLC
January/February/March 2025 | Volume 26, Issue 1
A Quarterly Review of NDAs
–January - March 2025
Neelam Sharma, Lavanya Kundurthy and Hemant N. Joshi, PhD, MBA
Tara Innovations LLC
April/May/June 2025 | Volume 26, Issue 2
A Quarterly Review of NDAs – April to June 2025
Neelam Sharma, Lavanya Kundurthy and Hemant N. Joshi, Ph.D., MBA
Tara Innovations LLC
july/August/September | Volume 26, Issue 3
A Quarterly Review of NDAs – July - September, 2025
Neelam Sharma MS, Lavanya Kundurthy BE and
Hemant N. Joshi, Ph.D., MBA
Tara Innovations LLC
October/November/December | Volume 26, Issue 4
Insider Insight
Optimizing
Product Packaging and Oral Drug Delivery with Stick Packs
Brent Moody, Director, Scientific Advisory Services
Catalent
Yannick Hildebrandt, Product Development Laboratory Manager
Catalent
july/August/September | Volume 26, Issue 3
Roundtable
Solid Dosage Trends
April/May/June 2025 | Volume 26, Issue 2
Supply Chain
Revolutionizing
Pharma Logistics: The Power of Intermodal Transportation
Mike Auerbach
Pharma Group Editor In Chief
January/February/March 2025 | Volume 26, Issue 1
From
Disruption to Stability: The Role of Supply Chain Resilience in CDMO Success
Davuluri Sucheth Rao
Vice-Chairman and Chief Executive Officer
Neuland Labs
April/May/June 2025 | Volume 26, Issue 2
How
Tariffs Could Impact Your Drug Development Supply Chain: Top Five Things to Be Aware Of
Maria Malin, Head of Financial Planning & Analysis
Jason Lenore, Senior Director of Supply Chain
Abzena
july/August/September | Volume 26, Issue 3
Why DSCSA Compliance in 2026 Hinges on Execution, Not Implementation
Michael Rowe, Sr. Director of DSCSA/Serialization Services
Two Labs
October/November/December | Volume 26, Issue 4